CSIMarket Company Name, Ticker, Customers, else..
 
Genfit S a   (NASDAQ: GNFT)
 

Genfit S A's Customers Performance

GNFT


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
GNFT's Source of Revenues During the corresponding time, Genfit S A recorded a revenue increase by 85.82 % year on year, While revenue at the Genfit S A 's corporate clients

• List of GNFT Customers




for the same period Genfit S A recorded revenue increase by 85.82 % year on year,

• List of GNFT Customers

Genfit S A's Business Units
Revenue From France    0 % of total Revenue
Licensing Agreement    21.57 % of total Revenue
Ipsen    12.26 % of total Revenue
Ipsen Licensing Agreement    68.65 % of total Revenue
Ipsen Transition Services Agreement    0.28 % of total Revenue






Genfit S A's Comment on Sales, Marketing and Customers



The company provides services to patients prescribed medications and their prescribing physicians, relying on third-party payors for coverage and reimbursement. These payors include government authorities such as Medicare and Medicaid in the United States, private health insurers, and health maintenance organizations. Coverage and adequate reimbursement from these entities are essential for product acceptance and use. The company also operates in the European Economic Area (EEA), where CE-marked in vitro diagnostics (IVDs) are subject to regulatory approvals and quality assurance notifications. Its market segments include healthcare payors and regulatory bodies responsible for product compliance and reimbursement.





Genfit S A’s Comment on Sales, Marketing and Customers


The company provides services to patients prescribed medications and their prescribing physicians, relying on third-party payors for coverage and reimbursement. These payors include government authorities such as Medicare and Medicaid in the United States, private health insurers, and health maintenance organizations. Coverage and adequate reimbursement from these entities are essential for product acceptance and use. The company also operates in the European Economic Area (EEA), where CE-marked in vitro diagnostics (IVDs) are subject to regulatory approvals and quality assurance notifications. Its market segments include healthcare payors and regulatory bodies responsible for product compliance and reimbursement.







GNFT's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Genfit S a 242.24 79.45 1.69 139
SUBTOTAL 0.00 0.00 0.00 -

Sources: Genfit S a’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Genfit S a’s corporate clients.
For your research, we’ve provided 9 tables on Genfit S a corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.